 |
 |
|
Date: 22 Jun 10 Time: 6.00 pm Venue: The Royal College of Physicians, 11 St Andrews Place, Regent's Park, London, Speakers: Dr Alan M.Garber, MD, PhD – Director of Stanford University’s School of Medicine Center for Health Policy and the Center for Primary Care and Outcomes Research Full Description "US Healthcare Reform: Monumental Health System Transformation, or Fatally Flawed Compromise?" by Dr Alan M.Garber, MD, PhD – Director of Stanford University’s School of Medicine Center for Health Policy and the Center for Primary Care and Outcomes Research To be held on 22 June 2010 at The Royal College of Physicians, 11 St Andrews Place, Regent's Park, London, by kind permission of the Treasurer at 6.00 pm. Followed by the OHE Summer Drinks Reception. The US Health Reform Act extended health coverage to 32 million uninsured Americans, preventing insurance companies from denying coverage to those with pre-existing medical conditions and requiring most Americans to buy health insurance. There has been skepticism about Government projections that the law will reduce federal deficits by $143 billion over 10 years and concern that the bill does not little to change the perverse incentives in the health-care system, leading to the broader concern that the bill will entrench a system with too little cost control and too few incentives to improve the efficiency of delivery and outcomes. Dr Garber will comment on the legislation from a unique perspective, being a practicing Professor of Medicine, one of the leading health economists in the world, and the Director of the Stanford University Center for Health Policy. He will provide an overview of the reform address issues relating to coverage, cost, and quality including: The full extent of expanded coverage, and effects of the legislation on the roles of public and private health insurance; What might happen to demand for services and the consequent implications for configuration of services (will there be more primary and preventative care and more integrated care pathways?) Will it lead to cost control now or in subsequent measures? Will cost-effectiveness criteria be widely used? Will either the Independent Medicare Payment Advisory Board or the tax on "gold plated" health insurance plans have an impact? Will the Patient Centered Outcomes Research Institute improve the quality of care? How will their findings be used? What will happen to drug use and drug prices? Dr. Garber is the Henry J. Kaiser Jr. Professor at Stanford University, where he is also a Professor of Medicine, and Professor (by courtesy) of Economics, Health Research and Policy, and of Economics in the Graduate School of Business. He has been Director of both the University's Center for Health Policy and the Center for Primary Care and Outcomes Research at the School of Medicine since their founding. Dr. Garber is a Staff Physician at the Veterans Affairs Palo Alto Health Care System, Scientific Adviser to the national Blue Cross and Blue Shield Association’s Medical Advisory Panel, a member of the Board of Health Advisers to the Congressional Budget Office, a member of the Institute of Medicine of the National Academy of Sciences, and of the Board on Science, Technology, and Economic Policy at the National Academies. He was the founding Director of the Health Care Program of the NBER. Dr. Garber is the recipient of numerous honors and awards, including the Rock Carling Fellowship of the Nuffield Trust (U.K.).After graduating from Harvard College summa cum laude, he received his PhD in economics from Harvard University and an MD with research honors from Stanford University. He was trained in internal medicine at Brigham and Women's Hospital in Boston. Reply form is at the link: |